Dr. Grant Cannon, M.D

NPI: 1942239439
Total Payments
$6,819
2020 Payments
$3,090
Companies
3
Transactions
8

Payment Breakdown by Category

Research$6,735 (98.8%)
Food & Beverage$44.77 (0.7%)
Education$39.98 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $6,735 5 98.8%
Food and Beverage $44.77 1 0.7%
Education $39.98 2 0.6%

Payments by Type

Research
$6,735
5 transactions
General
$84.75
3 transactions

Top Paying Companies

Company Total Records Latest Year
Amgen Inc. $6,735 5 $0 (2020)
Zimmer Biomet Holdings, Inc. $44.77 1 $0 (2017)
Gilead Sciences, Inc. $39.98 2 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2020 $3,090 2 Amgen Inc. ($3,090)
2019 $39.98 2 Gilead Sciences, Inc. ($39.98)
2018 $1,448 2 Amgen Inc. ($1,448)
2017 $2,241 2 Amgen Inc. ($2,196)

All Payment Transactions

8 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/03/2020 Amgen Inc. Enbrel (Biological) In-kind items and services $736.74 Research
Study: Empirical Evidence of Disease Activity Thresholds Used to Indicate Need for Major Therapeutic Chang • Category: Inflammation
03/19/2020 Amgen Inc. Enbrel (Biological) In-kind items and services $2,353.42 Research
Study: The Association of Disease Activity Measures with Major Therapeutic Change • Category: Inflammation
02/13/2019 Gilead Sciences, Inc. Education In-kind items and services $19.99 General
02/13/2019 Gilead Sciences, Inc. Education In-kind items and services $19.99 General
06/15/2018 Amgen Inc. Enbrel (Biological) In-kind items and services $892.68 Research
Study: The Ability of Disease Activity Measures to Predict Major Therapeutic Change in US Veterans with Rheumatoid Arthritis • Category: Inflammation
06/15/2018 Amgen Inc. Enbrel (Biological) In-kind items and services $555.47 Research
Study: The Association of Disease Activity Measures with Major Therapeutic Change • Category: Inflammation
10/25/2017 Zimmer Biomet Holdings, Inc. Tapered Screw (Device) Food and Beverage In-kind items and services $44.77 General
Category: Dental
03/01/2017 Amgen Inc. Enbrel (Biological) In-kind items and services $2,196.19 Research
Study: Poster, Compare persistence in patients initiating triple therapy vs. biologic combination therapy in the VA • Category: Inflammation

Research Studies & Clinical Trials

Study Name Company Amount Records
The Association of Disease Activity Measures with Major Therapeutic Change Amgen Inc. $2,909 2
Poster, Compare persistence in patients initiating triple therapy vs. biologic combination therapy in the VA Amgen Inc. $2,196 1
The Ability of Disease Activity Measures to Predict Major Therapeutic Change in US Veterans with Rheumatoid Arthritis Amgen Inc. $892.68 1
Empirical Evidence of Disease Activity Thresholds Used to Indicate Need for Major Therapeutic Chang Amgen Inc. $736.74 1

About Dr. Grant Cannon, M.D

Dr. Grant Cannon, M.D is a Rheumatology healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942239439.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Grant Cannon, M.D has received a total of $6,819 in payments from pharmaceutical and medical device companies, with $3,090 received in 2020. These payments were reported across 8 transactions from 3 companies. The most common payment nature is "" ($6,735).

Practice Information

  • Specialty Rheumatology
  • Location Salt Lake City, UT
  • Active Since 06/30/2006
  • Last Updated 07/09/2007
  • Taxonomy Code 207RR0500X
  • Entity Type Individual
  • NPI Number 1942239439

Products in Payments

  • Enbrel (Biological) $6,735
  • Tapered Screw (Device) $44.77

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Rheumatology Doctors in Salt Lake City